rdf:type |
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0012634,
umls-concept:C0205210,
umls-concept:C0205386,
umls-concept:C0205409,
umls-concept:C0226037,
umls-concept:C0439234,
umls-concept:C0441998,
umls-concept:C0444567,
umls-concept:C0449851,
umls-concept:C1273870,
umls-concept:C1274040,
umls-concept:C1542147,
umls-concept:C2348535
|
pubmed:issue |
11
|
pubmed:dateCreated |
2007-11-7
|
pubmed:abstractText |
Ostial disease of the left anterior descending (LAD) or circumflex (LCX) coronary artery is a challenge for the interventionalist. Focal ostial stenting may result in incomplete lesion coverage or plaque shift into the adjacent vessel, creating left main equivalent disease. The purpose of the present study was to address these concerns by using a left main bifurcation strategy with drug-eluting stents (DES) for the treatment of this problem.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1557-2501
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
457-61
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:17986719-Aged,
pubmed-meshheading:17986719-Aged, 80 and over,
pubmed-meshheading:17986719-Angioplasty, Balloon, Coronary,
pubmed-meshheading:17986719-Coronary Angiography,
pubmed-meshheading:17986719-Coronary Artery Disease,
pubmed-meshheading:17986719-Coronary Vessels,
pubmed-meshheading:17986719-Drug-Eluting Stents,
pubmed-meshheading:17986719-Female,
pubmed-meshheading:17986719-Follow-Up Studies,
pubmed-meshheading:17986719-Humans,
pubmed-meshheading:17986719-Male,
pubmed-meshheading:17986719-Middle Aged,
pubmed-meshheading:17986719-Treatment Outcome,
pubmed-meshheading:17986719-Ultrasonography, Interventional
|
pubmed:year |
2007
|
pubmed:articleTitle |
Isolated disease of the ostium left anterior descending or circumflex artery: management using a left main stenting technique. Clinical outcome at 2 years.
|
pubmed:affiliation |
Wake Heart and Vascular Associates, 3000 New Bern Avenue, Suite G100, Raleigh, NC 27610, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|